(R)-5-((3,4-Dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrile hydrochloride

Catalog No. :
ACAXCN038
CAS No. :
38176-02-2
Molecular Formula :
C27H39ClN2O4
Molecular Weight :
491.07

IUPAC Name:-

(R)-5-((3,4-Dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrile hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg95%$301.00Login to see priceInquiryInquiry
10mg95%$542.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-5-((3,4-Dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrile hydrochloride
Molecular FormulaC27H39ClN2O4
Molecular Weight491.07
SMILESN#C[C@](C(C)C)(C1=CC=C(OC)C(OC)=C1)CCCN(CCC2=CC=C(OC)C(OC)=C2)C.[H]Cl
InChI KeyDOQPXTMNIUCOSY-HZPIKELBSA-N
SynonymAKOS040736385 | UNII-B0P742MK5O | CARPRONIUM CHLORIDE [WHO-DD] | CHEBI:77739 | BENZENEACETONITRILE, .ALPHA.-(3-((2-(3,4-DIMETHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-3,4-DIMETHOXY-.ALPHA.-(1-METHYLETHYL)-, MONOHYDROCHLORIDE, (.ALPHA.R)- | B0P742MK5O | VERAPAM
CAS No.38176-02-2
PubChem CID170014

Safety Data

Pictogram
PICTOGRAM
Signal Word
Danger
Hazard Statement(s)
H301
Precautionary Statement(s)
P264-P270-P301+P310+P330-P405-P501

Synthetic Route by SureRoute

1. ACAXCN038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAXCN038 route product structure diagram
    ACAXCN03838176-02-2
Inquiry

2. ACAXCN038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAXCN038 route product structure diagram
    ACAXCN03838176-02-2
Inquiry

Comments (0)